Robin G Lorenz

Title: The Innovations of Robin G. Lorenz

Introduction

Robin G. Lorenz is a notable inventor based in Okeene, Oklahoma. He has made significant contributions to the field of pharmaceuticals through his innovative research. His work primarily focuses on novel peptides that exhibit gastrin-releasing peptide-like activity.

Latest Patents

Lorenz holds a patent for "Gastrin releasing peptide-like peptides." This patent describes novel peptides with the structures Ala-Pro-Val-Ser-Val-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro-NH.sub.2 and Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH.sub.2. These peptides have been isolated from rat and guinea pig brain extracts and synthesized using solid-phase peptide synthesis methods. The GRP-like peptides are useful as pharmaceuticals to lower body temperature, increase respiratory activity, reduce food intake, stimulate pancreatic hormone release, stimulate pituitary hormone release, and suppress thyroid hormone release in mammals.

Career Highlights

Lorenz is affiliated with Leland Stanford Junior University, where he continues to advance his research in peptide synthesis and its applications in medicine. His work has garnered attention for its potential therapeutic benefits.

Collaborations

Some of his notable coworkers include Jack D. Barchas and Eckard Weber, who have contributed to his research endeavors.

Conclusion

Robin G. Lorenz's innovative work in the field of gastrin-releasing peptide-like peptides showcases his dedication to advancing pharmaceutical science. His contributions have the potential to impact various medical applications significantly.